With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Yseop , a world leading Artificial Intelligence (AI) software company and pioneer in Generative AI, with support from Amazon Web Services (AWS), today announced the development of an enhanced Generative AI application for the Biopharma industry.
- NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Yseop , a world leading Artificial Intelligence (AI) software company and pioneer in Generative AI, with support from Amazon Web Services (AWS), today announced the development of an enhanced Generative AI application for the Biopharma industry.
- Yseop, with the support of AWS, is empowering the world’s top Biopharma companies to bring pharmaceuticals and vaccines to market even faster.
- “Yseop has built a unique Generative AI platform for regulatory document generation that can increase the rate at which new drugs are introduced, while addressing top concerns like security, performance, and data localization” said Emmanuel Walckenear, CEO of Yseop.
- “Yseop can now leverage capabilities like Amazon Sagemaker and Amazon Bedrock to meet the strict AI software and data requirements across Biopharma."